Toggle navigation
Home
Search
Services
Blog
Contact
About
PS10-1013: Increas. Acc. to Qual. Comp. HIV Prevention Services for Most-at-R
Gelmon, Lawrence
University of Manitoba, Winnipeg, MB, Canada
Search 19 grants from Lawrence Gelmon
Search grants from University of Manitoba
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Transcriptomic Identification of Vagal Motor Neurons That Differentially Regulate Gastric Function
Molecular characterization of congenital cataract
Training Program in Basic and Clinical Communication Science
Tpa Mediated Neurodegeneration and Microglia Activation
Cities of the Future - Wingspread Workshop: Racine, Wisconsin; Spring/Summer 2006
Recently added grants:
Pulmonary Mechanisms of Dyspnea in HFpEF: Impact of Obesity
Molecular Mechanisms of Semaphorin/Plexin-mediated Cytoskeletal Reorganization
Behavioral and mechanistic dissection of a cognitive thalamo-cortical network
Cellular and Circuit Mechanisms of Temporal Lobe Epilepsy
Mechanisms of mitochondrial disease suppression in Ndufs4 knockout mice
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Center for HIV, Viral Hepatitis, STDS and Tb Prevention (NCHHSTP)
Type
Global HIV/AIDS Non-Research Cooperative Agreements (U2G)
Project #
3U2GPS002846-05S2
Application #
9205297
Study Section
Special Emphasis Panel (ZPS1-SRC (99))
Project Start
2010-09-30
Project End
2016-09-29
Budget Start
2014-09-30
Budget End
2016-09-29
Support Year
5
Fiscal Year
2016
Total Cost
$2,860,831
Indirect Cost
Institution
Name
University of Manitoba
Department
Type
DUNS #
207584707
City
Winnipeg
State
MB
Country
Canada
Zip Code
R3 2-N2
Related projects
Publications
Mital, Sasha; Miles, Gillian; McLellan-Lemal, Eleanor et al.
(2016)
Heroin shortage in Coastal Kenya: A rapid assessment and qualitative analysis of heroin users' experiences.
Int J Drug Policy 30:91-8
Comments
Be the first to comment on Lawrence Gelmon's grant